Biogen to buy experimental Alzheimer’s, Parkinson’s treatment from Pfizer for $75M plus incentives

Biogen to buy experimental Alzheimer’s, Parkinson’s treatment from Pfizer for $75M plus incentives
Biogen has agreed to buy an early-stage experimental treatment for patients with Alzheimer's and Parkinson's disease from Pfizer for $75 million, plus up to $635 million in potential milestones, as ... read more
Source: Bing NewsPublished on 2020-01-13